INCYTE CORP (INCY) Form 10-K Annual Reports
INCYTE CORP (INCY) is a publicly traded company on the Nasdaq, categorized under SIC 8731 (Services-Commercial Physical & Biological Research). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: INCY
CIK: 879169
Exchange: Nasdaq
SIC 8731: Services-Commercial Physical & Biological Research
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2016 12:00:00 AM
Lead Engagement PartnerAnthony Masherelli
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 144 | 2026-10-15 | — | 144 Filing | 0001950047-26-010228 | View SEC Doc Filr Page |
| 4 | 2026-10-05 | 2026-10-01 | FORM 4 | 0002039219-26-000010 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | 4 | 0001193125-26-412653 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001409601-26-000015 | View SEC Doc Filr Page |
| 4 | 2026-10-02 | 2026-09-30 | FORM 4 | 0001177917-26-000014 | View SEC Doc Filr Page |
| 4 | 2026-09-24 | 2026-09-22 | FORM 4 | 0002085970-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-09-17 | 2026-09-15 | FORM 4 | 0001205703-26-000030 | View SEC Doc Filr Page |
| 144 | 2026-09-15 | — | 144 Filing | 0001950047-26-009470 | View SEC Doc Filr Page |
| 8-K | 2026-08-31 | 2026-08-31 | 8-K | 0000879169-26-000058 | View SEC Doc Filr Page |
| 4 | 2026-08-27 | 2026-08-25 | FORM 4 | 0002083591-26-000007 | View SEC Doc Filr Page |
| 4 | 2026-08-20 | 2026-08-19 | FORM 4 | 0001205703-26-000028 | View SEC Doc Filr Page |
| 144 | 2026-08-19 | — | 144 Filing | 0001950047-26-008386 | View SEC Doc Filr Page |
| 4 | 2026-08-14 | 2026-08-12 | FORM 4 | 0001205703-26-000027 | View SEC Doc Filr Page |
| 144 | 2026-08-12 | — | 144 Filing | 0001950047-26-008001 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0001205703-26-000025 | View SEC Doc Filr Page |
| 4 | 2026-08-07 | 2026-08-05 | FORM 4 | 0002079962-26-000015 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001950047-26-007678 | View SEC Doc Filr Page |
| 144 | 2026-08-05 | — | 144 Filing | 0001950047-26-007673 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0001205703-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-08-04 | 2026-07-31 | FORM 4 | 0002079962-26-000013 | View SEC Doc Filr Page |
| 144 | 2026-08-03 | — | 144 Filing | 0001950047-26-007554 | View SEC Doc Filr Page |
| 144 | 2026-07-31 | — | 144 Filing | 0001950047-26-007474 | View SEC Doc Filr Page |
| 144 | 2026-07-31 | — | 144 Filing | 0001950047-26-007453 | View SEC Doc Filr Page |
| 10-Q | 2026-07-28 | 2026-06-30 | 10-Q | 0000879169-26-000056 | View SEC Doc Filr Page |
| 8-K | 2026-07-28 | 2026-07-28 | 8-K | 0000879169-26-000053 | View SEC Doc Filr Page |